Table 6.

 Inactivation of emerging pathogens by pasteurization (60°C for 10 h in aqueous stabilized solution) [CSL Behring on file].

Virus	Inactivation factor (log10)	Time to complete ablation of viral infectivity (h)
Enveloped viruses
SARS‐CoV; TGEV*	≥4.0; ≥4.1 (≥6.1)†	1; 1 (4)†
Influenza A viruses
FPV/Rostock/34 (H7N1)	≥5.4	1
Chick/Pennsylvania/1/83 (H5N2)	≥4.9	2
PR/8/34 (H1N1)	≥4.9	1
Non‐enveloped virus
HEV/FCV‡	≥5.0	1

*Emerging virus studied/model virus studied: BVDV, bovine viral diarrhoea virus; SARS‐CoV, SARS coronavirus; TGEV, transmissible gastroenteritis virus; WNV, west nile virus.

^†Different detection limits at 1 and 4 h.

^‡Human virus (model virus studied): HEV, hepatitis E virus; FCV, feline calici virus.